Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 24, 2018 - Issue 3
184
Views
7
CrossRef citations to date
0
Altmetric
Articles

A new MAPT deletion in a case of speech apraxia leading to corticobasal syndrome

ORCID Icon, , , &
Pages 140-144 | Received 18 Dec 2017, Accepted 18 Jun 2018, Published online: 03 Jul 2018

References

  • Alexander, S. K., Rittman, T., Xuereb, J. H., Bak, T. H., Hodges, J. R., & Rowe, J. B. (2014). Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. Journal of Neurology, Neurosurgery, and Psychiatry, 85, 925–929.
  • Appollonio, I, Leone, M, Isella, V, Piamarta, F, Consoli, T, Villa, M. L, & Nichelli, P. (2005). The frontal assessment battery (fab): normative values in an italian population sample. Neurological Sciences, 26(2), 108-116.
  • Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., … Weiner, W. J. (2013). Criteria for the diagnosis of corticobasal degeneration. Neurology, 80, 496–503.
  • Assal, F., Laganaro, M., Remund, C. D., & Ragno Paquier, C. (2012). Progressive crossed-apraxia of speech as a first manifestation of a probable corticobasal degeneration. Behavioural Neurology, 25, 285–289.
  • Bizzozero, I, Lucchelli, F, Saetti, M. C, & Spinnler, H. (2007). “whose face is this?”: italian norms of naming celebrities. Neurological Sciences, 28(6), 315-322. doi:10.1007/s10072-007-0845-6
  • Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., … Petersen, R. C. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53, 795–800.
  • Caffarra, P, Vezzadini, G, Dieci, F, Zonato, F, & Venneri, A. (2002). Rey-osterrieth complex figure: normative values in an italian population sample. Neurol Sci, 22(6), 443-447. doi:10.1007/s100720200003
  • Carlesimo, G. A, Caltagirone, C, Gainotti, G, Fadda, L, Gallassi, R, Lorusso, S, & Parnetti, L. (1996). The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. European Neurology, 36(6), 378-384.
  • De Renzi, E, & Lucchelli, F. (1988). Ideational apraxia. Brain, 111(5), 1173-1185. doi:10.1093/brain/111.5.1173
  • Delazer, M, Girelli, L, Gran�, A, & Domahs, F. (2003). Number processing and calculation ? normative data from healthy adults. The Clinical Neuropsychologist, 17(3), 331-350. doi:10.1076/clin.17.3.331.18092
  • Deramecourt, V., Lebert, F., Maurage, C. A., Fernandez-Gomez, F. J., Dujardin, S., Colin, M., … Buee, L. (2012). Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. Journal of Alzheimer’s Disease: JAD, 31, 741–749.
  • Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011). Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). Journal of Molecular Neuroscience: MN, 45, 384–389.
  • Duffy, J. R. (2005). Motor speech disorders: Substrates, differential diagnosis, and management 2nd edition (St Louis, MO: Mosby). Google Scholar.
  • Flanagan, E. P., Baker, M. C., Perkerson, R. B., Duffy, J. R., Strand, E. A., Whitwell, J. L., … Josephs, K. A. (2015). Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dementia and Geriatric Cognitive Disorders, 39, 281–286.
  • Franceschi, M., Caffarra, P., Savare, R., Cerutti, R., & Grossi, E. (2011). Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer’s disease. Behav Neurol, 24(2), 149–158.
  • Galimberti, D., & Scarpini, E. (2012). Clinical phenotypes and genetic biomarkers of FTLD. Journal Neural Transm (Vienna), 119, 851–860.
  • Giovagnoli, A. R, Del Pesce, M, Mascheroni, S, Simoncelli, M, Laiacona, M, & Capitani, E. (1996). Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci, 17(4), 305-309. doi:10.1007/BF01997792
  • Goodglass, H, & Kaplan, E. (1983). Boston diagnostic examination for aphasia. Philadelphia: Lea & Febiger.
  • Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M., & Mandelkow, E. (1994). Domains of tau protein and interactions with microtubules. Biochemistry, 33, 9511–9522.
  • Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurology, 5, 228–234.
  • Josephs, K. A., & Duffy, J. R. (2008). Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Current Opinion in Neurology, 21, 688–692.
  • Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Gunter, J. L., … Whitwell, J. L. (2014). The evolution of primary progressive apraxia of speech. Brain: A Journal of Neurology, 137, 2783–2795.
  • Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Master, A. V., … Whitwell, J. L. (2012). Characterizing a neurodegenerative syndrome: Primary progressive apraxia of speech. Brain: A Journal of Neurology, 135, 1522–1536.
  • Kouri, N., Carlomagno, Y., Baker, M., Liesinger, A. M., Caselli, R. J., Wszolek, Z. K., … Rademakers, R. (2014). Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathologica, 127, 271–282.
  • Luzzatti, C., Willmes, K., & De Bleser, R. (1996).Aachener aphasie test: versione italiana. Giunti Organizzazioni Speciali. Firenze.
  • Marshall, C. R., Guerreiro, R., Thust, S., Fletcher, P., Rohrer, J. D., & Fox, N. C. (2015). A novel MAPT mutation causing corticobasal syndrome led by progressive apraxia of speech. Journal of Alzheimer’s Disease: JAD, 48, 923–926.
  • Monaco, M, Costa, A, Caltagirone, C, & Carlesimo, G. A. (2013). Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an italian adult population. Neurol Sci, 34(5), 749-754. doi:10.1007/s10072-012-1130-x
  • Mondini, S., Mapelli, D., Vestri, A., & Bisiacchi, P. S. (2003). Esame neuropsicologico breve. Milano: Raffaello Cortina Editore, 160.
  • Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011). The many faces of tau. Neuron, 70, 410–426.
  • Mulder, C., Verwey, N. A., Van Der Flier, W. M., Bouwman, F. H., Kok, A., Van Elk, E. J., … Blankenstein, M. A. (2010). Amyloid-beta(1–42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clinical Chemistry, 56, 248–253.
  • Rossi, G., Marelli, C., Farina, L., Laura, M., Maria Basile, A., Ciano, C., … Pareyson, D. (2008). The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Movement Disorders: Official Journal of the Movement Disorder Society, 23, 892–895.
  • Rossi, G., & Tagliavini, F. (2015). Frontotemporal lobar degeneration: Old knowledge and new insight into the pathogenetic mechanisms of tau mutations. Frontiers in Aging Neuroscience, 7, 192.
  • Santos-Santos, M. A., Mandelli, M. L., Binney, R. J., Ogar, J., Wilson, S. M., Henry, M. L., … Rosenberg, L. (2016). Features of patients with nonfluent/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurology, 73, 733–742.
  • Spinnler, H, & Tognoni, G. (1987). Standardizzazione e taratura italiana di test neuropsicologici. Masson Italia Periodici.
  • Spires-Jones, T. L., Stoothoff, W. H., De Calignon, A., Jones, P. B., & Hyman, B. T. (2009). Tau pathophysiology in neurodegeneration: A tangled issue. Trends in Neurosciences, 32, 150–159.
  • Tessari, A., Toraldo, A., Lunardelli, A., Zadini, A., & Rumiati, R. I. (2011). Prova standardizzata per la diagnosi del disturbo aprassico ideomotorio selettivo per tipo di gesto e tipo di effettore. Ricerche di Psicologia.
  • Warrington, E. K. (1996). Short Recognition Memory Test for Faces: Psychology Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.